Gene · 6383
Papers4,416
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,416
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anoikis-related signature identifies tumor microenvironment landscape and predicts prognosis and drug sensitivity in colorectal cancer. | J Cancer | 2024 | 38213716 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy. | BMC Med | 2024 | 38185631 | PubTator, text mining | PubMed |
| CD317+ MSCs expanded with chemically defined media have enhanced immunological anti-inflammatory activities. | Stem Cell Res Ther | 2024 | 38169422 | PubTator, text mining | PubMed |
| LSD1 Regulates Neurogenesis in Human Neural Stem Cells Through the Repression of Human-Enriched Extracellular Matrix and Cell Adhesion Genes. | Stem Cells | 2024 | 38152966 | PubTator, text mining | PubMed |
| Biophysical characterization of the Plasmodium falciparum circumsporozoite protein's N-terminal domain. | Protein Sci | 2024 | 38059674 | PubTator, text mining | PubMed |
| Ligand concentration determines antiviral efficacy of silica multivalent nanoparticles. | J Colloid Interface Sci | 2024 | 38043234 | PubTator, text mining | PubMed |
| Sulfated liposome-based artificial cell membrane glycocalyx nanodecoys for coronavirus inactivation by membrane fusion. | Bioact Mater | 2024 | 38024234 | PubTator, text mining | PubMed |
| Listen to Your Gut: Key Concepts for Bioengineering Advanced Models of the Intestine. | Adv Sci (Weinh) | 2024 | 38009508 | PubTator, text mining | PubMed |
| Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for Resectable Gastric Cancer : Prognosis Prediction for Resectable GC. | Ann Surg Oncol | 2024 | 37996637 | PubTator, text mining | PubMed |
| Soluble vascular endothelial glycocalyx proteoglycans as potential therapeutic targets in inflammatory diseases. | Immunol Cell Biol | 2024 | 37982607 | PubTator, text mining | PubMed |
| Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors. | Eur J Med Chem | 2024 | 37981443 | PubTator, text mining | PubMed |
| Apolipoprotein C3: form begets function. | J Lipid Res | 2024 | 37972731 | PubTator, text mining | PubMed |
| RAB31 in glioma-derived endothelial cells promotes glioma cell invasion via extracellular vesicle-mediated enrichment of MYO1C. | FEBS Open Bio | 2024 | 37953466 | PubTator, text mining | PubMed |
| Characterization of nanodisc-forming peptides for membrane protein studies. | J Colloid Interface Sci | 2024 | 37801850 | PubTator, text mining | PubMed |
| APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation. | Alzheimers Dement | 2024 | 37791598 | PubTator, text mining | PubMed |
| DNA methylation drives a new path in gastric cancer early detection: Current impact and prospects. | Genes Dis | 2024 | 37692483 | PubTator, text mining | PubMed |
| Biomedical applications of engineered heparin-based materials. | Bioact Mater | 2024 | 37609108 | PubTator, text mining | PubMed |
| TGIRT-seq of Inflammatory Breast Cancer Tumor and Blood Samples Reveals Widespread Enhanced Transcription Impacting RNA Splicing and Intronic RNAs in Plasma. | medRxiv | 2024 | 37398275 | PubTator, text mining | PubMed |
Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin. | Cardiovasc Drugs Ther | 2024 | 36401727 | PubTator, text mining | PubMed |
| The chylomicron saga: time to focus on postprandial metabolism. | Front Endocrinol (Lausanne) | 2023 | 38303975 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6383/papers?page=12